MEASuRE: Metreleptin Effectiveness And Safety Registry

The study is a post-authorization, prospective, voluntary registry of patients treated with commercial metreleptin including, but not limited to, patients in the US and EEA.

NCT Number	NCT02325674
Lead Sponsor	Chiesi Farmaceutici S.p.A.
Conditions	Generalised Lipodystrophy, Partial Lipodystrophy
Enrollment	100 participants
Start Date	2016-10-11
Primary Completion	2031-10-31 (estimated)
Study Completion	2031-10-31 (estimated)
Updated on ClinicalTrials.gov	2026-07-16